Author:
Bodyak Natalya,Yurkovetskiy Alexander V.
Publisher
Springer International Publishing
Reference86 articles.
1. A pilot study of 64-Cu labeled brain PET/MRI for MM-302, a novel HER2 targeting agent, in advanced HER2+ cancer with brain metastases – NCT02735798
2. A study evaluating MM-310 in patients with solid tumors – NCT03076372
3. Ali MF, Salah M, Rafea M, Saleh N (2008) Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit 14(12):PI66–PI74
4. Anami Y, Xiong W, Gui X, Deng M, Zhang CC, Zhang N, An Z, Tsuchikama K (2017) Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drugconjugates with high potency. Org Biomol Chem 15(26):5635–5642
5. Bardia A, Mayer IA, Diamond JR, Moroose RL, Isakoff SJ, Starodub AN, Shah NC, O’Shaughnessy J, Kalinsky K, Guarino M, Abramson V, Juric D, Tolaney SM, Berlin J, Messersmith WA, Ocean AJ, Wegener WA, Maliakal P, Sharkey RM, Govindan SV, Goldenberg DM, Vahdat LT (2017) Efficacy and safety of anti-Trop-2 antibody drug conjugate sacituzumab govitecan (IMMU-132) in heavily pretreated patients with metastatic triple-negative breast Cancer. J Clin Oncol 35:2141
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献